logo

Revelation Biosciences Inc (REVB) Stock: A Year of Stock Market Dynamics

CSCO Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Revelation Biosciences Inc’s current trading price is -94.50% away from its 52-week high, while its distance from the 52-week low is 23.42%. The stock’s price range over this period has fluctuated between $2.22 and $49.80. The company, operating within the financial sector, had a trading volume of approximately 0.32 million for the day, which was noticeably lower than the average daily share volume of 0.39 million over the last 3 months.

Revelation Biosciences Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $49.80 on 04/17/23 and a low of $2.22 for the same time frame on 03/19/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Revelation Biosciences Inc (REVB) has experienced a quarterly decline of -81.44% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.10M and boasts a workforce of 9 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.87, with a change in price of -15.06. Similarly, Revelation Biosciences Inc recorded 246,793 in trading volume during the last 100 days, posting a change of -84.60%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for REVB stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

REVB Stock Stochastic Average

Today’s raw stochastic average for Revelation Biosciences Inc over the last 50 days is 2.26%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 34.21%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 21.14% and 14.85%, respectively.

REVB Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -81.76% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -86.67%. Over the past 30 days, the price of REVB has leaped by -33.50%. And in the last five days, it has surged by 11.84%.